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ABSTRACT
Effect of Antioxidants and Oxidative Stress on Different
Cancer Cell Types
Gaytri Gupta Elera
Department of Microbiology and Molecular Biology, BYU
Master of Science
Vaccinium cyanococcus, most commonly known as blueberry, is a fruit native to North America
that is known for its unique taste and high antioxidant content. The skin, seed and juice of both
organically and conventionally grown blueberry extract were analyzed for antioxidant content
using both the Hydrophilic and Lipophilic Oxygen Radical Absorbance Capacity (ORAC)
assays. Results from the Hydrophilic ORAC test showed that conventionally grown blueberries
had a higher antioxidant capacity across all samples, while the Lipophilic ORAC assay showed
that the antioxidant concentration of organically cultivated blueberry juice was highest, but
conventionally grown blueberry seed and skin extract showed higher antioxidant content. The
vitamin C content of both conventional and organic blueberries were analyzed using High
Performance Liquid Chromatography (HPLC), where the organic blueberries showed a higher
vitamin C concentration. In general, both organic and conventional blueberries are rich in
antioxidants, and therefore, possess potential health benefits that require further study.
Abbreviations: AAPH, 2,2'-azobis(2-aminidopropane) dihydrochloride; ORAC, oxygen radical
absorbance capacity; ROS, Reactive Oxygen Species; TE, Trolox Equivalents; AUC, area under
the curve.

Keywords: blueberry, antioxidant, organic, conventional, ORAC.
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SUMMARY OF WORK
Cancer, although one of the leading causes of death in the United States, is a lifestyle
disease, where correlations have been observed between lifestyle choices and cancer incidences.
Due to this, interest has risen in dietary antioxidants as a means of lowering cancer risk and as
potential therapeutic biomarkers for different cancer cell types. This thesis revolves around the
potential health benefits of antioxidants and the role of oxidative stress on different cancer cell
lines. Each study presented has been published.
The study that has been accepted for publication in the Journal of Food Research explores
potential health benefits of organically and conventionally grown blueberries by comparing
differences in antioxidant concentration using different antioxidant measuring techniques.
The appendix section contains two papers that have already been published. The first
paper, titled “The antioxidant properties of cherimoya (Annona cherimola) fruit”, examines the
health benefits of cherimoya consumption by measuring its antioxidant content, and also
explores the effect of this fruit on Raji (Burkitt’s Lymphoma) and HT-29 (colon cancer) cells.
An alternate cellular model was also established to investigate the effects of oxidative stress on
antioxidant absorbance of these two cell lines.
The second paper, titled “The Role of Oxidative Stress on Prostate Cancer”, is a review
that summarizes the effects of oxidative stress on prostate cancer initiation and development,
while also exploring the therapeutic potential of antioxidants and regulators of reactive oxygen
species. Overall, this thesis is centered on the role antioxidants and oxidative stress might play
in the prevention of different cancer cell types.
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1. Introduction
In recent years, there has been a rising interest in organically cultivated foods as an
alternative to conventional agricultural techniques, which has led to an increase in the acreage
assigned to organic cultivations (Carbonaro, Mattera, Nicoili, Bergamo, & Cappeloni, 2002).
Differences between these farming techniques are attributed to fertilizer type and pesticide use.
Conventional farming techniques involve the use of mineral fertilizers and synthetic pesticides,
while organic farming techniques use organic fertilizers and no synthetic pesticides.
Whether it is more beneficial for the consumer to purchase organic instead of
conventional foods remains a hot topic of discussion. Although most people are under the
impression that organically cultivated foods are more beneficial (Worthington, 2004), the
experimental evidence to support this claim remains unclear and assessment of the health
benefits of these products still requires further investigation.
Interest in the consumption of foods with the greatest health benefit potential has become
more prevalent because epidemiological studies suggest that the consumption of both an
antioxidant and phytochemical-rich diet contribute to the reduction of heart disease and several
types of cancer (Chinery et al., 1998).
As a result, there has been substantial amount of interest in Vaccinium corymbosum,
commonly known as blueberries, due to this fruit’s anti-tumor properties in different cancer
types such as colon cancer (Yi, Fisher, Krewer, & Akoh, 2005), breast cancer (Adams et al.,
2010), and prostate cancer (Schmidt, Erdman, & Lila, 2006). Blueberries are native to North
America, and are known to contain high contents of both antioxidants, such as phenolic acid and
resveratrol, and phytochemicals, such as flavonoids and tannins (Seeram, 2008).
Antioxidants provide protection against oxidative stress, a condition that has been
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suggested to contribute to a wide variety of diseases, including artherosclerosis, Parkinson’s
disease, and cancer (Amira, 2010). Oxidative stress occurs when the levels of reactive oxygen
species (ROS) and reactive nitrogen species (RNS) increase to a level that propagates oxidative
injury in DNA, lipids and proteins. Damage to DNA is an early event in carcinogenesis, and
oxidation is known to induce 2’-4’-oxidative DNA damage that may lead to the formation of
DNA-protein cross-links, alterations in the carbohydrate-phosphate backbone, or direct
modification of purine or pyrimidine bases. If these alterations lead to the activation of
oncogenes or the inactivation of tumor suppressor genes, cancer may develop (Gupta-Elera,
Garrett, Martinez, Robison, & O’Neill, 2010). Therefore, antioxidants such as phenolic acid
protect cells against oxidative stress by scavenging oxygen free radicals, and functioning as
metal chelators (Russo et al., 2000). Resveratrol, another antioxidant found in blueberries,
additionally reduces levels of ROS by increasing the levels of MnSOD, an enzyme that reduces
superoxide to hydrogen peroxide (Robb, Page, Wiens, & Stuart, 2008), and also interferes with
carcinogenesis by inducing Fas/Fas ligand-mediated apoptosis (Cao, Fu, Wang, Liu, & Han,
2005).
Phytochemicals have both antioxidant and hormone mimicking actions, and they exert
their anticancer effects through different mechanisms, such as the induction of metabolizing
enzymes, alteration of gene expression, modulation of cell signaling pathways and DNA repair
(Seeram, 2008). Phytochemicals in blueberries have been shown to decrease the secretion of
urokinase-type plasminogen activator (uPA) and increase the secretion of plasminogen activator
inhibitor (PAI), both of which are cell-signaling proteins that inhibit tumor cell proliferation and
metastatic potential in breast cancer cells (Adams et al., 2010). Anthocyanin, the flavonoid
responsible for the pigmentation in blueberries, has both antioxidant and anti-cancer properties
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(Seeram, Yanjun, & Muraleedharan, 2003). A study that explored the potential anticancer
activities of polyphenols in rabbiteye blueberries on HepG2 liver cancer cells found that the
anthocyanin fraction had the greatest inhibitory effect with 50% inhibition of cancer cell growth,
thus suggesting that blueberries may help reduce the risk of liver cancer (Yi, Akoh, Fischer, &
Krewer, 2006).
The main objective of this research was to provide preliminary results on the differences
in antioxidant concentrations between conventionally and organically grown blueberries,
specifically by examining extracts of their juice, skin and seed; and, therefore, provide insight
into the health benefits of organic vs. conventional blueberries.
2. Materials and Methods
2.1 Chemicals
The 2,2'-azobis(2-aminidopropane) dihydrochloride (AAPH) was purchased from Wako
Chemicals USA, Inc. (Richmond, VA). Fluorescein-sodium salt, Metaphosphoric Acid,
methylated β-cyclodextrin, and DL-Dithiothreitol (threo-1,4-dimercapto-2,3-butanediol) were
obtained from Sigma-Aldrich, Inc. (Milwaukee, WI). Trolox (6-hydroxy-2,5,7,8-tetramethyl-2carboxylic acid) was purchased from Enzo Life Sciences, Inc. (Plymouth, PA). Acetonitrile,
methanol, and acetone were purchased from Baxter (Muskegon, MI).
2.2 Materials
Costar 96-well plate and 24-well clear culture plates were purchased from Corning Inc.
(Lowell, MA).
2.3 Equipment
All fluorescence readings were taken using the BMG FLUOstar Optima (BMG
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Laboratories) microplate reader (serial #413-0225). HPLC readings were made using the Agilent
1100 Zorbax SB-Aq (serial # USVD001136). Data were analyzed using Microsoft Excel and
Apple Numbers.
2.4 Fruit Sample
Ten different lots of both conventional and organic highbush blueberry fruits were
purchased at a local grocery store in Provo, UT on the day of importation. Organic blueberries
carried the USDA organic label. Both organic and conventional blueberries were grown in
Michigan.
2.5 Sample preparation
Blueberry skin, seed and juice were isolated and were then homogenized by weighing 0.1
g of sample and diluting it in 10 ml of double distilled water. Samples were centrifuged at 1800
rpm for 15 minutes, placed in aliquots of 2.5 ml and kept in a freezer at -20° C until analyzed.
2.6 Hydrophilic and Lipophilic ORAC
All samples were analyzed using a modified ORAC assay based on published methods
(Garrett, Murray, Robison, & O’Neill, 2010; Huang, 2002). The ORAC assay measures
oxidative degradation of a fluorescent compound (fluorescein sodium salt) after being exposed to
an oxygen radical initiator, AAPH (2,2’-azobis-(2-amidinopropane) dihydrochloride). All
readings were taken in Cole-Parmer black bottom 96-well plates, with 200µl Fluorescein, 25µl
AAPH, and 20µl of antioxidant sample or PBS in each well.
The Lipophilic ORAC was performed in duplicate as described for the Hydrophilic
ORAC, except that the solvent used to dilute the sample was 7% randomly methylatedcyclodextrin (RMCD) in acetone/water (1:1 v/v) solution.
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Readings were taken every 2 minutes for 90 minutes. Measurements were taken by the
BMG FLUOstar Microplate reader at 37°C; 485 nm excitation and 590 nm emission filters were
used for fluorescence readings. All fluorescent measurements were expressed relative to the
initial reading. The area under the curve (AUC) was calculated by using the difference of area
under the fluorescein decay curves between the sample curve and the fluorescein + AAPH curve.
The AUC measures the total antioxidant activity in the sample minus the fluorescein + AAPH
antioxidant curve. Lipophilic and Hydrophilic ORAC values were measured separately and the
Total Antioxidant Capacity (TAC) was calculated by summing the L-ORAC and H-ORAC
values.
2.7 Standard Curve Data
Trolox, a water-soluble analogue of vitamin E, was used as a control standard. Trolox
standards were run at concentrations of 50µM, 25µM, 12.5µM, and 6.25µM to obtain standard
curves for each trial. Data from each standard curve was used to convert raw net area under the
sample curve (net AUC) values to Trolox Equivalents per liter (TE/L). Subsequent calculations
converted TE/L to TE/100g (see Figure A.1)
2.8 High-Performance Liquid Chromatography
All samples were measured using an Agilent 1100 (US) HPLC system coupled with an
Agilent 1100 diode array detector and equipped with Agilent 1100 binary pumps based on
published methods (Nielson, 2006). Samples consisting of 5 μL were injected at ambient
temperature (20 °C) into a Reverse phase Zorbax SB-Aq (4.6x150 mm 3.5 μm) with C18 guard
column. An Isocratic mobile phase consisting of MeOH/Sodium Acetate (3/97) with a pH of 4.0
was used with a flow rate of 1mL/min. Vitamin C content was identified by its UV spectra,
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recorded with a diode array detector and by chromatographic comparison with authentic
markers. Scanning between 190 and 400 nm was performed, and data were collected by the
Agilent Chemstation data system. Data collection time was 30 minutes.
3. Results
3.1 Hydrophilic ORAC Values
As shown in Figure 1, hydrophilic antioxidant analysis of conventional blueberry skin,
seed and juice extract resulted in higher antioxidant values when compared to the organic
blueberries, across all samples. Juice exhibited the highest measured antioxidant activity, with
the conventional yielding a value of 9,806 TE/100g (stdev=3851, N=30), and the organic
yielding a value of 5,258 TE/100g (stdev=2649, N=30). The next highest activity was found in
the skin at 7,891 TE/100g (stdev=2311, N=30) for conventional, and at 4,623 TE/100g
(stdev=2337, N=30) for organic. Finally, the lowest activity was measured in the seed, with the
conventional at 1,015 TE/100g (stdev=524, N=30), and the organic at 636 TE/100g (stdev=283,
N=30).

Figure 1. Differences in antioxidant content between organic and conventional blueberry juice,
skin, and seed extract using H-ORAC. All values are reported as TE/100g (Mean of N=30).
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3.2 Lipophilic ORAC Values
As shown in Figure 2, lipophilic antioxidant analysis of the conventional blueberry skin
and seed extract resulted in a higher antioxidant content in comparison to the organic blueberry
samples, while the organic juice extract resulted in a higher antioxidant content than that of the
conventional. The highest measured antioxidant activity was found in the juice, with the organic
yielding a value of 35,156 TE/L (stdev=2,183, N=30), and the conventional yielding a value of
31,535 TE/L (stdev=2,281, N=30). The next highest activity was observed in the skin at 13,755
TE/100g (stdev=2,593, N=30) for conventional, and at 11,833 TE/100g (stdev=1,687, N=30) for
organic. Finally, the lowest activity was found in the seed, with the conventional at 10,727
TE/100g (stdev=2,198, N=30), and the organic at 8,709 TE/L (stdev=1,830, N=30).

Figure 2. Differences in antioxidant content between organic and conventional blueberry juice,
skin, and seed extract using L-ORAC. All values are reported as TE/100g (Mean of N=30).
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3.3 Vitamin C content using HPLC
High-Performance Liquid Chromatography analysis of whole organic blueberries resulted
in a higher vitamin C content than whole conventional blueberries, as shown in Figure 3.
Organic blueberries yielded a value of 592.879 μg/g (stdev=42.406, N=5), while conventional
blueberries had 386.947 μg/g (stdev=40.172, N=5).

Figure 3. Difference in vitamin C content between organic and conventional blueberry using
HPLC. All values are reported as µg/g.
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4. Discussion
4.1 Analysis of H-ORAC and L-ORAC values
When the extracts of blueberry seed, skin and juice were analyzed for antioxidant activity
using the Hydrophilic ORAC, conventionally grown blueberries exhibited higher antioxidant
content across all samples. Statistical significant changes in antioxidant content were observed in
blueberry skin (p<0.01), seed (p<0.05), and juice (p<0.01) components, with conventional
samples possessing more antioxidant activity. This might be explained in part by the difference
in nutrient composition between organic and mineral fertilizers. Organic fertilizers have a lower
nutrient content, solubility and nutrient release rates, thus making the nutrients, such as nitrogen,
less readily available to plants. Therefore, the blueberry plant grown in an organic environment
has to allocate more of its resources towards the synthesis of nitrogen-containing compounds and
towards its growth and development, whereas conventionally grown blueberries can allocate
their resources elsewhere (Seghers et al., 2003).
The Lipophilic ORAC provided different results. The extract of organic blueberry juice
showed a statistically significant increase (p<0.001) in antioxidant concentration when compared
to conventional blueberry juice. On the other hand, conventionally grown blueberries showed a
statistically significant increase of antioxidants in their skin (p<0.001) and seed (p<0.001), when
compared to its organic blueberry components. Winter & Davis (2006) have suggested that a
potential reason that could account for the elevated antioxidant content in organic blueberry juice
is that since organically grown blueberries do not have synthetic pesticides, the plant has to build
its own chemical defenses against pathogens, thus increasing their antioxidant concentrations.
However, they also argued that conventionally-grown blueberry plants are also subjected to
stress due to their exposure to sub-lethal doses of chemicals found in both herbicides and
9

pesticides, and in response, they increase their antioxidants and phytochemicals so that they can
act as chemical barriers against pathogens (Winter & Davis, 2006).

Figure 4. Differences in total antioxidant content between organic and conventional blueberry
juice, skin, and seed extract. All values are reported as TE/100g (Mean of N=5).

4.2 Analysis of Vitamin C content using HPLC
Results showed that organically grown blueberries had a 53.4% antioxidant increase
when compared to conventionally grown blueberries. Ascorbic acid reduces reactive oxygen
species to prevent oxidative damage, and also reduces vitamin E to activate it and restore the
antioxidant protection of the cell membrane (O'Neill, Standage, Hughes, & Murray, 2001). The
decreased amount of vitamin C in conventionally grown blueberries could be due to the synthetic
fertilizer. The amount of nitrogen in the fertilizer might affect the amount of vitamin C and
nitrates, and the amount of protein produced by the plant. Since plants that are conventionally
grown are presented with a higher concentration of nitrogen, its protein production is increased,
while its carbohydrate production is reduced. Consequently, the amount of vitamin C produced
is reduced, since it is made from carbohydrates (Seghers et al., 2003).
This is consistent with results from a review that surveyed 41 studies in the existing
10

literature comparing the nutritional content of organic and conventional crops in order to identify
significant differences; and trends in the data found that, on average, the vitamin C content of an
organic fruit or vegetable was 27% higher than that of a conventional fruit or vegetable
(Worthington, 2004).
Student’s one tail t-test (6.69e-30) and two tail t-test (1.34e-29) show that there is a
statistically significant difference in vitamin C capacity between organic and conventional
blueberries.
4.3 Analysis of total ORAC values
As shown in Figure 4, when the total antioxidant capacity for the H-ORAC and L-ORAC
are analyzed, conventional blueberries have a higher total antioxidant content, with 33,388
TE/100g and 607,700 TE/L, respectively, in comparison to 25,800 TE/100g and 415,608 TE/L
for organic blueberries. Student t-test analyses performed on data revealed that the differences in
antioxidant content of juice, skin and seed between organically- and conventionally- grown
blueberries were statistically statistically significant: p<0.01, p<0.01, and p<0.01, respectively.
Overall, the blueberry fruit is very rich in antioxidants, with ORAC values higher than
blackberries, strawberries and grapes (Haytowitz & Bhagwat, 2010). A study that analyzed the
flavonoid and phenolic acid profiles of 19 different berries, including cranberry, raspberry and
strawberry, suggested that blueberries had the highest total phenolic content (Häkkinena et al.,
1999). This suggests that the potential health benefits of blueberries is high, and may, thereby,
prevent the initiation and progression of diseases that have been linked to oxidative stress, such
as cancer, cardiovascular diseases and neurodegenerative diseases.
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5. Conclusion
Results showed although organic and conventional blueberries are both very rich in
antioxidants, conventional blueberries have higher antioxidant content, and, therefore, may have
a higher overall health benefit potential in reducing cancer risk. However, organic blueberries
have higher vitamin C content when analyzed with HPLC. This study also suggests that it is
important to consume both the juice and skin of the fruit to maximize antioxidant intake.
Further chemical analyses are needed to more fully understand the chemical composition
in these blueberry components and the specific antioxidant compounds they contain. Further
research may also include establishing a cellular model, where different cancer cell lines can be
exposed to both organic and conventional blueberry juice, skin and seed extract where the
concentration of antioxidants that is absorbed by the cell can be measured. This may provide
insight into how effectively the cells take in the antioxidants, and ultimately, add insight into the
potential role of blueberries in the prevention of different cancer types.
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a b s t r a c t
Annona cherimola is an exotic fruit from the genus Annona, native to the Andean highlands in western South
America. The cherimoya skin, ﬂesh and juice were isolated and analyzed for antioxidant content using the
oxygen radical absorbance capacity (ORAC) assay. The juice showed the highest antioxidant activity, while the
ﬂesh exhibited the lowest. The cherimoya skin, ﬂesh and juice extracts were also incubated with Raji
(Burkitt's Lymphoma) and HT-29 (colon cancer) cell lines, and the antioxidant uptake of cells was measured.
Both cell lines, when subjected to cherimoya juice, showed the highest antioxidant uptake. The cells were
then exposed to AAPH, a radical initiator, to simulate the conditions of cells under oxidative stress, and then
subjected to cherimoya skin, ﬂesh and juice extracts. Both cell lines absorbed more antioxidants after being
pre-exposed to AAPH, indicating that cells under stress have the ability to import antioxidants.
© 2010 Elsevier Ltd. All rights reserved.

1. Introduction
Annona cherimola, commonly known as cherimoya, is a species of
fruit found in different subtropical areas around the world, mainly in
northern Peru and southern Ecuador. Cherimoya is known to have been
cultivated during the times of the Incan Empire, dating back to 1200 BC.
Anthropological evidence suggests that the cherimoya fruit was an
active ingredient in the Incan diet (Bonavia, Ochoa, Tovar, & Palomino,
2004). The cherimoya fruit is known for its exceptional taste, its use in
traditional medicine as an antimicrobial and insecticide, and as an
effective treatment for digestive disorders such as stomachache and
pancreatic ulcers (Amoo, Emenike, & Akpambang, 2008).
Considerable evidence suggests that oxidative stress leads to the
development of conditions such as cancer and heart disease the two
leading causes of death in the United States (Tribble & Frank, 1994; Xu,
Kochanek, Murphy, & Tejada-Vera, 2010). Oxidative stress occurs when
the production of reactive oxygen species (ROS) exceeds antioxidant
capacity, which leads to oxidative damage. Partially reduced forms of
oxygen, such as superoxide and hydrogen peroxide, that are produced
during aerobic metabolism have the potential of causing oxidative
injury to macromolecules such as nucleic acids, proteins and lipids.
Oxygen radicals are capable of initiating radical chain-reactions that
propagate oxidative injury (O'Neill, Standage, Hughes, & Murray, 2001).
DNA damage is an early event in carcinogenesis, and oxidation is known
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to induce 2′-4′-oxidative DNA damage which may lead to the formation
of DNA–protein cross-links, alterations in the carbohydrate-phosphate
backbone, or direct modiﬁcation of purine and pyrimidine bases.
Tumors may develop if alterations in DNA lead to the activation of
oncogenes or the inactivation of tumor suppressor genes.
Dietary antioxidants found in bioactive food components exert
regulatory effects on cell proliferation and cytotoxicity. Antioxidants
such as vitamin C, vitamin E, soy sterols, and polyphenols help protect
the cell against oxidant-induced proliferation, lipid peroxidation,
glutathione peroxidase activation (Garcia-Alonso, Ros, & Periago, 2006;
Ou, Huang, Hampsch-Woodill, Flanagan, & Deemer, 2002), and also
contribute to thyroid regulation and glucose homeostasis (Panda, Kar, &
Patil, 2009). Evidence indicates that A. cherimola is rich in antioxidants
such as vitamins A and C, making it a beneﬁcial health supplement
(Garcia, Zepeda-Vallejo, Gallegos, Gonzales, & Madrigal, 2008).
Interest in this fruit has also risen due to its high concentration of
acetogenins, which are polyketides that act as secondary metabolites in
plants. Research has accredited beneﬁcial effects to acetogenins,
including the induction of cytotoxic, anti-inﬂammatory and antitumorous activities, particularly in mammary, pancreatic, prostatic,
and colon cancer cells (Chen, Chang, Chiu, Wu, & Wu, 1999). Analysis of
twelve acetogenins in Annona cornifolia, a fruit related to A. cherimola,
revealed through DPPH radical-scavenging activity that acetogenins
contain antioxidant capacity, comparable to that of ascorbic acid (Santos
Lima, Pimenta, & Boaventura, 2010). Acetogenins are thought to exert
their effects through the inhibition of the ubiquinone oxido-reductase
complex in the mitochondrial electron transport chain and the
inhibition of NADH oxidase in the plasma membrane. Acetogenins
contained in the stems of A. cherimola (Chen et al., 1999) and the seeds
of Annona reticulata (Chen, Chang, Chiu, Wu, & Wu, 1998) have been
isolated and identiﬁed, however, antioxidant properties of these
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acetogenins have yet to be assessed in order to evaluate their potential
for use in dietary supplements.
This project explores the potential health beneﬁts of cherimoya
consumption by examining the antioxidant activity of its individual
components, including skin, ﬂesh and juice using the oxygen radical
absorbance capacity (ORAC) assay. The cherimoya extracts were also
incubated with Raji (Burkitt's Lymphoma) cells and HT-29 (colon
cancer) cells to measure antioxidant uptake. Incubations with cherimoya juice extract exhibited the highest antioxidant uptake in both cell
lines. Cells were stressed by exposure to 2,2′-azobis(2-aminidopropane) dihydrochloride (AAPH) and then exposed to cherimoya extracts
to measure their antioxidant uptake. Results showed that cells under
oxidative stress import more antioxidants when incubated with
cherimoya skin, ﬂesh, and juice extract, thus suggesting the potential
beneﬁts of consuming antioxidants following exercise.

2.5.2. Changing media
Used media was discarded and cells were washed with 5 mL of
Hank's solution. One mL of 0.05% trypsin-EDTA at 37 °C was added to
the ﬂask and evenly dispersed over the surface. The ﬂask was placed
in the 37 °C incubator and observed until the cells were detached from
the walls of the ﬂask. After centrifugation at 450 g for 15 min, the
trypsin was discarded, the pellet of cells was resuspended in 5 mL of
McCoy media, re-seeded in a ﬂask. The new media introduced was
used to rinse the surface of the ﬂask and was pipetted up and down to
dissociate cell clumps. A cell count and viability test was performed
via trypan blue using a hemocytometer. Cell viability was maintained
above 90% and cell counts were maintained between 900,000 and
1,100,000 cells/mL.

2. Materials and methods

All the cherimoya fruits were purchased at a local grocery store in
Orem, UT, and were stored in a refrigerator at 3 °C.

2.6. Fruit sample

2.1. Chemicals
2.7. Sample preparation
2,2′-azobis(2-aminidopropane) dihydrochloride (AAPH) was purchased from Wako Chemicals USA, Inc. (Richmond, VA). RPMI 1640
medium was purchased from Hyclone (Logan, UT). Cosmic Calf Serum
was purchased from Hyclone (Logan, UT). L-glutamine was obtained
from Fisher Scientiﬁc (Pittsburgh. PA). Fluorescein-sodium salt was
obtained from Sigma-Aldrich, Inc. (Milwaukee, WI). Hank's Balanced
Solution was purchased from Hyclone (Logan, UT). Trolox (6-hydroxy2,5,7,8-tetramethyl-2-carboxylic acid) was purchased from Enzo Life
Sciences, Inc. (Plymouth, PA). Phosphate buffered saline (PBS) was
purchased from Sigma-Aldrich, Inc. (Milwaukee, WI).

Cherimoya skin and ﬂesh were excised from the fruit and
homogenized by weighing 0.4 g of sample and diluting it in 10 mL
of distilled water. Juice was extracted through the compression of the
cherimoya ﬂesh. Juice was then homogenized to reduce possible
interference from fruit constituents, according to recent methodological recommendations (Perez-Jimenez et al., 2008). Samples were
centrifuged at 450 g for 15 min, ﬁlter-sterilized and kept in a freezer at
−20 °C until used.
2.8. Oxygen radical absorbance capacity (ORAC) assay

2.2. Materials
Costar 96- and 24-well clear culture plates were purchased from
Corning Inc. (Lowell, MA). Raji cells (Burkitt's Lymphoma cell line) and
colon cancer cells (HT-29) were obtained from the American Type
Culture Collection (ATCC).
2.3. Equipment
All ﬂuorescence readings were taken using the BMG FLUOstar
Optima (BMG Laboratories) microplate reader (serial #413-0225). All
data were analyzed using Microsoft Excel and Apple Numbers.
2.4. Burkitt's Lymphoma cell culture
2.4.1. Growth medium
RPMI 1640 Medium was supplemented with 10% Fetal Bovine Serum
and 2 mM of L-glutamine. Cells were kept in an incubator with 5%
carbon dioxide at 37 °C.

All samples were analyzed using a modiﬁed ORAC assay based on
published methods (Garrett, Murray, Robison, & O'Neill, 2010). The
ORAC assay measures oxidative degradation of a ﬂuorescent compound (ﬂuorescein sodium salt) after being exposed to an oxygen
radical initiator, AAPH (2,2′-azobis(2-aminidopropane) dihydrochloride). All readings were taken in Cole-Parmer black bottom 96-well
plates, with 133 μL Fluorescein (0.1 μM), 50 μL AAPH (4 μM), and
13 μL of antioxidant sample or PBS in each well. Readings were taken
every 2 min for 1 h, followed by readings every 15 min for 3 h.
Measurements were taken by the BMG FLUOstar Microplate reader at
37 °C; 485 nm excitation and 590 nm emission ﬁlters were used for
ﬂuorescence readings. All ﬂuorescent measurements were expressed
relative to the initial reading. The area under the curve (AUC) was
calculated by using the difference of area under the ﬂuorescein decay
curves between the sample curve and the ﬂuorescein + AAPH curve.
The AUC measures the total antioxidant activity in the sample minus
the ﬂuorescein + AAPH antioxidant curve.
2.9. Standard curve data

2.4.2. Changing media
Cells were placed in a conical vial and centrifuged at 450 g for
15 min. Spent media was discarded and new RPMI media was
introduced. The conical vial containing new media was vortexed
and placed in incubation plates. Cell count and viability were
determined via trypan blue staining using a hemocytometer. Cell
viability was maintained above 90% and cell counts were maintained
between 900,000 and 1,100,000 cells/mL.

Trolox, a water-soluble analogue of vitamin E, was used as a
control standard. Trolox standards were run at concentrations of
50 μM, 25 μM, 12.5 μM, and 6.25 μM to obtain standard curves for each
trial. Data from each standard curve were used to convert raw net area
under the sample curve (net AUC) values to Trolox Equivalents per
liter (TE/L). Subsequent calculations converted TE/L to TE/100 g.
2.10. Antioxidant concentration of samples only

2.5. HT-29 (colon) cancer cell culture
2.5.1. Growth medium
McCoy Medium was supplemented with 10% Fetal Bovine Serum
and 1.5 mM L-glutamine. Cells were kept in an incubator with 5%
carbon dioxide at 37 °C.

Fifty μL of PBS was inserted in the ﬁrst and last columns of the 96well plate and 133 μL of ﬂuorescein was inserted into rows 2–11. The
cherimoya skin, ﬂesh and juice extract were placed in a 37 °C water
bath for 10 min. 13 μL of skin sample was added to rows 2–4, 13 μL of
ﬂesh sample was added to rows 5–7 and 13 μL of juice sample was
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added to rows 8–9. Mixtures were pipetted up and down to ensure
homogeneity of the mixture. After the ﬂuorescein was measured
twice in a two minute interval using the FLUOstar Optima ﬂuorescence microplate reader, 50 μL of AAPH was placed in rows 2–10.
Fluorescein levels were recorded in 2 minute intervals for 1 h,
followed by 15 minute intervals for 3 h.
2.11. Antioxidant uptake cellular model
One mL of cells was placed in each well of the 24-well plate, and each
column of the plate was mixed with 100 μL of cherimoya skin, ﬂesh or
juice extract. One mL of cells with 100 μL of PBS served as the control.
The incubation plate was placed in the incubator for 20 min. The
samples from each well were then placed in labeled eppendorf vials that
were centrifuged for 15 min at 450 g. The supernatant was discarded. To
perform the wash, 1 mL of sterilized PBS was added to each eppendorf
vial and vortexed until the cells were suspended in solution. The
eppendorf vials were subjected to a 37 °C water bath for 3 min and then
to a liquid nitrogen bath for 3 min. The freeze/thaw process was
repeated three times. The eppendorf vials were centrifuged for 30 min
at 3000 g. The supernatant (cell lysate) was then placed in a 96-well
plate to perform the ORAC assay to determine antioxidant uptake in the
cells.
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(stdev = 1257, N = 48). Measurements on each extract were repeated
four times, with 12 replicates for each sample, giving a total of 48
measurements per sample. Data represent mean values for each.
3.2. Raji incubations
Initial assessment of antioxidant activity in a Raji cell lysate
following incubation with PBS revealed a ﬁnal Trolox Equivalent value
of 2147 TE/100 mg sample per 1,100,000 cells (N = 36). All of the
following data are reported in TE/100 g sample per 1,100,000 cells.
Incubations with cherimoya skin, ﬂesh, and juice extracts revealed
higher TE values for each sample when compared to PBS controls
(4136 for cherimoya skin, N = 36; 2580 for cherimoya ﬂesh, N = 36;
5830 for cherimoya juice, N = 36). Assessments taken from each
sample following pre-exposure to AAPH revealed increased antioxidant activity in each sample, including the PBS control (4097,
N = 36). Sample data revealed a mean value of 5895 (N = 36) for the
cherimoya skin extract, 6939 (N = 36) for the cherimoya ﬂesh extract,
and 7527 (N = 36) for the cherimoya juice extract (see Fig. 1).
3.3. HT-29 incubations

One mL of cells with 100 μL of a 1:16 dilution of AAPH:sterile PBS
was placed in each well of the 24-well plate. The incubation plate was
placed in the incubator for 10 min. The cells were then placed in
eppendorf vials and centrifuged for 15 min at 450 g. The supernatant
was discarded and 1 mL of PBS was added to each eppendorf vial and
vortexed so the cells were re-suspended. Vials were again centrifuged
for 15 min at 450 g. The supernatant was discarded and 1 mL of cell
media was added to the eppendorf vials and vortexed until cells were
re-suspended. The cells with the media were placed in each well of
the 24-well incubation plate, and an additional 100 μL of cherimoya
skin, ﬂesh or juice extract was added. The plate was placed in the
incubator for 20 min and same procedure outlined earlier was
followed to measure the antioxidant uptake of the cells.

Assessment of HT-29 cell lysate antioxidant activity revealed
trends similar to those found in the Raji lysates (Fig. 2). Initial
measurement of PBS control-incubated HT-29 cell lysate revealed a
mean TE value of 1521 (N = 24). Data for cherimoya-incubated HT-29
samples revealed a mean value of 2904 (N = 24) for the cherimoya
skin extract, 1760 (N = 24) for the cherimoya ﬂesh extract, and 5644
(N = 24) for the cherimoya juice extract. Pre-exposure to AAPH
resulted in higher antioxidant assessments for each sample, including
PBS controls: 7769 (N = 24) for PBS control, 10,343 (N = 24) for
cherimoya skin extract, 10,433 (N = 24) for cherimoya ﬂesh extract,
and 11,929 (N = 24) for cherimoya juice extract. The same trend
observed in the Raji cell model was observed in the HT-29 cells, in that
the highest overall values were seen in the juice-incubated cell lysate.
In contrast to data for Raji cells, however, the ﬂesh and skin-incubated
cell lysates were almost equal, where the values for the skinincubated cell lysates were larger than the ﬂesh-incubated cell lysate
in the Raji model.

2.13. Cytotoxicity

4. Discussion

To eliminate the possibility that the cells were exhibiting higher
antioxidant uptake because the cell membrane was being damaged by
AAPH exposure, Raji cells, with a cell count between 900,000 and
1,100,000 cells/mL and a viability above 90%, were treated with 1:1,
1:2, 1:4, 1:8 and 1:16 dilutions of AAPH in sterile PBS in a 24-well
plate. After being exposed to the different concentrations of AAPH,
cells were placed in the incubator for 24 h. The cell count and viability
for each well containing the different dilutions of AAPH were
determined via trypan blue staining using a hemocytometer. The
1:16 dilution of AAPH sterile PBS maintained cell viability and the cell
count had increased, showing that the AAPH treatment had not
substantially damaged the cell membrane, as to affect the cell
integrity.

4.1. Analysis of raw cherimoya extracts

2.12. Simulation of oxidative stress: an alternate cellular model

3. Results

The current study's antioxidant analyses of raw cherimoya
extracts, to our knowledge, represent the ﬁrst attempt at such
quantiﬁcation using the ORAC assay, although 1,1-Diphenyl-2picrylhydrazyl radical (DPPH) assay analyses have been previously
preformed (Vasco, Ruales, & Kamal-Eldin, 2008). When each
individual cherimoya component was analyzed for antioxidant
activity, the juice exhibited the highest antioxidant activity while
the skin contained the lowest. This may be due to the higher
concentrations of vitamins A and C found in the fruit ﬂesh (16.63 μg/
100 g of vitamin A and 42.38 mg/100 g of vitamin C) (Amoo et al.,
2008). Further analysis and testing of the skin and fruit composition
are needed to provide additional insight into the compounds present
in each part of the fruit that contribute to their overall antioxidant
capacities.

3.1. Raw cherimoya extract
4.2. Incubation analysis
Antioxidant analyses of several cherimoya skin, ﬂesh and juice
extracts yielded the following data: The highest measured antioxidant
activity was found in the cherimoya juice at 98,085 TE/100 g
(stdev = 12,017, N = 48). The next highest activity was in the
cherimoya skin at 74,714 TE/100 g (stdev = 6614, N = 48), and the
lowest activity was found in the cherimoya ﬂesh at 6004 TE/100 g

Raji cells and HT-29 cells were exposed to cherimoya skin, ﬂesh
and juice extracts and the antioxidant capacity of the cell lysates were
measured. Antioxidant values in the cellular models were signiﬁcantly
different from the raw antioxidant extract levels themselves. This is
likely due to the dynamic cellular processes that allow antioxidant
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Fig. 1. Changes in antioxidant activity in Raji cell lysates before and after incubation with AAPH. All values were reported as TE/100 g sample per 1,100,000 cells.

compounds from the medium to cross the cellular membrane into the
cellular interior. Individual cells are also equipped with their own
processes to cope with oxidative stress, resulting in increased
antioxidant protection. Both Raji and HT-29 cells exposed to
cherimoya juice exhibited higher antioxidant activity in their cell
lysates (when compared to those exposed to skin or ﬂesh extract),
while cells exposed to cherimoya skin extract had the lowest
antioxidant activity of the group. This suggests that the antioxidant
compounds in the cherimoya juice are both readily accessible and
beneﬁcial to the cells for uptake. By contrast, the cherimoya ﬂesh, for
example, either does not contain usable antioxidant compounds or is
lacking in antioxidant content.
Student's t-tests performed on data also revealed statistically
signiﬁcant increases in antioxidant capacity in both Raji (one-tailed
p = 0.016) and HT-29 (one-tailed p = 0.0006) models. This suggests
that both cell lines are equipped to respond to the oxidative stresses
with which they are presented, and encourages further study of more
broad and diverse cell lines.
Overall, it was observed that HT-29 cells produced a much greater
percent increase in their antioxidant activities following exposure to
oxidative stress. The average percent increase for all Raji runs was 82.9%
(max= 169%, min = 29.1%, stdev = 62.2), while the average percent
increase for all HT-29 runs was 318% (max = 493%, min = 111%,
stdev = 169). Student's t-test analysis revealed that the difference in
HT-29 cellular response compared to that of the Raji cells was
statistically signiﬁcant (p= 0.013). These results suggest that the HT29 cell line may be more robust in its ability to respond to oxidative
stress and react to protect itself against these stresses. Further testing of
this and other cell lines may be beneﬁcial in determining common
cellular responses in various cell types. Such analyses may also help to
elucidate the mechanisms responsible for responding to oxidative stress
in varying cell types. It appears from the data mentioned earlier that the
cell lines tested have the ability to sense oxidative damage and
correspondingly increase their uptake of available antioxidants. Further

research regarding different levels of oxidative stress exposure, as well
as experiments with different classes of antioxidants, may prove
beneﬁcial in understanding the mechanisms involved in cellular
responses to oxidative stress.
From the PBS results (Figs. 1 and 2), it can be seen that cells
exposed to oxidants internally increase their antioxidant capacity.
However, cells exposed to fruit extracts substantially increase their
intracellular antioxidant levels and these increases are higher than the
basal antioxidant levels in the cells, indicating that cells have the
ability to import available antioxidants when experiencing oxidative
stress. It is interesting to note that while the cherimoya juice is the
most potent antioxidant under conditions of oxidative stress, there is
a much higher percentage increase in antioxidant activity when
exposed to skin and ﬂesh. This is signiﬁcant because it suggests
beneﬁts from the consumption of all components of Cherimoya fruit,
including skin, ﬂesh and juice.
5. Conclusion
The ﬁrst objective of this research was to analyze the antioxidant
capacities of the A. cherimola fruit, speciﬁcally examining its skin,
ﬂesh, and juice. Initial analyses suggested that A. cherimola contains
high antioxidative properties, and that the highest antioxidative
potential is found ﬁrst in the plant's juice, and next in its skin. Further
chemical analyses of A. cherimola are needed to more fully understand
its chemical composition and the antioxidant compounds it contains.
Future research may also include studying the plant's stem, leaves,
and ﬂowers for antioxidant activity and chemical composition.
Regular consumption of A. cherimola may contribute to increased
antioxidant capacity of human serum, and may thereby help to
prevent the development and progression of cardiovascular disease,
neurodegenerative diseases, cancer, and other diseases thought to be
linked to oxidative stress. Further studies are needed to add insight
into the potential role of A. cherimola in the prevention of these

Fig. 2. Changes in antioxidant activity in HT-29 cell lysates before and after incubation with AAPH. All values were reported as TE/100 g sample per 1,100,000 cells.
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conditions. Additional studies are needed to further elucidate the
intracellular mechanisms that may be contributing to the increased
antioxidant capacity in these and other cell lines. Further study may
also provide insights on the effects of changes of baseline oxidative
stress in humans and how these changes affect tolerance to oxidative
stress in future stressful environments. Additional insights may be
gained into the effects of exercise on oxidative stress and the body's
ability to protect its tissues during future stressful events. These
insights may also aid in the future study of the development and
progression of oxidative stress-induced degenerative conditions, and
how oxidative-antioxidant equilibria may increase prevention against
such conditions.
As a second focus of this paper, the effects of pre-exposure to
oxidative stress on cellular antioxidant uptake were examined, using
A. cherimola extracts as the source of antioxidants. The data indicate that
pre-exposure to oxidative stress may contribute to increased antioxidant uptake in both Raji and HT-29 cell lines. In both cell lines, cell lysate
antioxidant capacity was signiﬁcantly higher when cells were exposed
to oxidative stress, suggesting that the presence of oxidative stress
contributed to the uptake of antioxidants as part of a cellular response
mechanism. These data correlate with similar studies on the effect of
pre-exposure to inﬂammation-inducing environments on tissues
(Schmid-Schonbein, 2006), and suggest that the mechanisms that
inﬂuence these responses should be studied further on the cellular level.
Results show that while cherimoya juice is a potent antioxidant,
ﬂesh and skin consumption, along with the juice, will allow a higher
antioxidant uptake when cells are placed under oxidative stress.
Therefore, when consuming cherimoya, it is beneﬁcial to include all
parts of the fruit. Further research may shed light on the use of
A. cherimola as a useful dietary supplement.
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The role of oxidative stress in prostate cancer
Gaytri Gupta-Elera, Andrew R. Garrett, Richard A. Robison and Kim L. O’Neill
Reactive oxygen species (ROS) and reactive nitrogen
species (RNS) are not only byproducts of normal cellular
metabolism, but also play important roles in cell signaling.
However, when the levels of ROS and RNS increase, cells
are exposed to oxidative stresses, which activate a variety
of mechanisms to allow them to cope with these changes.
Studies have shown that oxidative stress conditions play
an important role in both the initiation and the progression
of prostate cancer by regulating molecules such as DNA,
enhancers, transcription factors, and cell cycle regulators.
Other studies have shown that antioxidants, molecules that
protect cells against oxidative stress, play a role in
prevention of prostate cancer. This review summarizes the
effects of oxidative stress on the development of prostate
cancer and explores the potential of ROS regulators as

preventatives for prostate cancer. European Journal of
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Introduction

profiles, a diet high in saturated fats, and family
predisposition (Rohrmann et al., 2007; Cheung et al.,
2008; Heymach et al., 2010), thus suggesting the
importance of lifestyle in reducing the risk of prostate
cancer.

Prostate cancer is the most common type of cancer in
men and the second leading cause of cancer death in men
after lung cancer (Jemal et al., 2010). The prostate is a
male gland located below the bladder that begins to
develop before birth due to the presence of androgens.
The function of the prostate is to store and secrete an
alkaline fluid, which makes up approximately one-third of
the volume of semen. This fluid contributes significantly
to both the viability and motility of the sperm during the
fertilization process. On average, one man in six is
diagnosed with prostate cancer and one in 36 dies from it.
The American Cancer Society estimates approximately
217 730 new cases of prostate cancer and 32 050 resulting
deaths in 2010 (Society, 2010). Statistical data suggest
that prostate cancer can be very aggressive. This, coupled
with its high incidence, makes further study of prostate
cancer necessary.
Although prostate cancer is relatively common, there are
genetic and environmental risk factors that increase the
probability of developing prostate cancer. Prostate cancer
is usually an age-correlated disease, meaning the chances
of developing prostate cancer increase significantly with
age. Approximately two of three cases of prostate cancer
are found in men over 65 years of age (Society, 2010).
Race also contributes to prostate cancer mortality: there
is a higher incidence and death rate from prostate cancer
among African-American men. In contrast, prostate
cancer is less common in the Asian-American and
Hispanic populations. Although the reasons for these
trends are unknown (Fedewa et al., 2010), diet may play a
significant role. Besides ethnicity and aging, prostate
cancer can also be influenced by smoking, hormone
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Prostate disorders
Although prostate cancer is the most destructive type of
prostate disease, there are other diseases of the prostate,
including benign prostatic hyperplasia (BPH) and prostatitis.
Benign prostatic hyperplasia

BPH, also known as adenofibromyomatous hyperplasia,
refers to the enlargement of the prostate that often
occurs in middle-aged men. It is one of the most common
types of prostate disease, and is present in more than 60%
of men aged between 50 and 60 years (Miner et al., 2006).
BPH is characterized by the hyperplasia of prostatic
stromal and epithelial cells, which leads to the formation
of nodules that compress the urethral canal. This
compression leads to an obstructed urethra, which
interferes with urine flow. Studies have shown that when
BPH cells are subjected to mild oxidative stress by being
treated with low concentrations of hydrogen peroxide
(H2O2), their proliferation rate increases. The treatment
of these cells with vitamin E and selenium reverses the
proliferation, thus suggesting a possible role of antioxidants in BPH prevention (Lonn et al., 2005).
Prostatitis

Although BPH is the most common prostate disease in
men over 50 years, prostatitis is the most common disease
in men aged less than 50 years of age (Potts and
DOI: 10.1097/CEJ.0b013e32834a8002
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Pasqualotto, 2003). Prostatitis refers to the inflammation of
the tissue in the prostate and is divided into four
categories: (a) acute bacterial prostatitis, a bacterial
infection of the prostate; (b) chronic bacterial prostatitis,
a rare condition characterized by frequent urinary tract
infections; (c) chronic prostatitis/chronic pelvic pain
syndrome, which accounts for 90–95% of prostatitis
diagnoses; and (d) asymptomatic inflammatory prostatitis, characterized by leukocytosis and infection-fighting
cells in the semen. These cells in the semen are a rich
source of reactive oxygen species (ROS) that may lead to
oxidative stress conditions, contributing to sperm damage
and infertility.
Prostate cancer malignancy

The most aggressive type of prostate disease is prostate
cancer. It is classified as an adenocarcinoma and is most
common in the peripheral zone. More than 40% of men
diagnosed with prostate cancer experience tumor metastasis, which is the spread of the cancer to sites such as the
bones, lymph nodes, rectum, and bladder (Society, 2010).
A condition known as prostatic intraepithelial neoplasia
(PIN) is believed to be a precursor of prostate cancer. PIN
is characterized by prostatic epithelial cells that are similar,
both phenotypically and genotypically, to those of cancer,
as opposed to normal prostatic epithelial cells (Bostwick,
2000). The ideal time to detect and treat prostate cancer
is before it has invaded other parts of the body.

Prostate cancer detection
Although late stage prostate cancer incidence can be
reduced with early detection, prostate cancer diagnostic
methods are limited in both specificity and sensitivity.
Early diagnosis methods include prostate-specific antigen
(PSA) blood testing, a digital rectal examination, and
tissue biopsy. PSA is a protein made in the prostate, and
most healthy men have a PSA level less than 4 ng/ml in
the blood. If PSA levels are between 4 and 10 ng/ml, the
chance of prostate cancer is approximately 25%, and if the
PSA levels exceed 10 ng/ml, the chance of prostate cancer
is more than 50% (Borgermann et al., 2010). PSA,
however, is not specific to prostate cancer, as PSA levels
often rise due to age and prostatitis. Factors that can
cause PSA levels to decrease, even when the patient has
prostate cancer, include obesity and some medicines used
to treat BPH and urinary symptoms. The digital rectal
examination is a physical rectal examination, in which the
physician feels for irregularities. This form of diagnosis is
less effective than PSA blood testing and centrally
located tumors are easily missed. Tissue biopsy is the
most accurate; however, its limitations include its
invasiveness and sampling errors that can lead to false
diagnoses. Biopsy is the only detection method for PIN,
as serum PSA is not usually elevated and PIN cannot be
detected by ultrasound (Bostwick, 2000). Novel detection methods with an increased sensitivity and specificity

are needed, which will require a better understanding of
the cellular and molecular mechanisms involved in the
development of prostate cancer.

Oxidative stress and its effects on early
carcinogenesis
The effect of oxidative stress on prostate cancer has been
extensively studied in order to better understand the
development of prostate cancer malignancy. Oxidative
stress occurs when the production of ROS exceeds
antioxidant capacity, leading to oxidative damage. ROS
can be produced from both endogenous and exogenous
sources. The body naturally produces ROS through
different mechanisms, such as oxygen reacting with
metal ions in the body and through reactions in the
mitochondrial electron transport chain that reduce O2 to
H2O. The body can also be exposed to ROS exogenously
through cigarette smoking and chemical exposure. UV
light and other radiation can also lead to increases in ROS
in the body. These partially reduced forms of oxygen,
such as superoxide and H2O2, are produced during
aerobic metabolism and have the potential to cause
oxidative injury to macromolecules such as nucleic acids,
proteins, and lipids through radical chain reactions.
Oxidative damage to nucleic acids such as DNA is an
early event in carcinogenesis. 20 -40 -oxidative DNA
damage leads to the formation of DNA–protein crosslinks, alterations in the carbohydrate–phosphate backbone, or direct modification of purine or pyrimidine
bases. If these alterations in the DNA lead to the
activation of oncogenesis or the inactivation of tumor
suppressor genes, cancer may develop.
There are other factors that exist within the cell that can
lead to the generation of oxidative stress and, therefore,
prostate cancer. Androgens, such as testosterone, are
hormones involved in the development of male organ
such as the prostate. Androgens, although necessary for
prostate development, can also lead to BPH and prostate
cancer if BPH overgrowth occurs. Recent research has
examined the role that androgens play in androgeninduced oxidative stress in androgen-sensitive human
prostate adenocarcinoma (LNCaP) cells. A study showed
that androgen receptor-induced ROS production is
related to increased levels of JunD, a protein belonging
to the activator protein 1 family of transcription factors
that has been shown to inhibit cell proliferation and
promote cell differentiation (Church et al., 2005). A
subsequent study used cell constructs that overexpressed
and underexpressed JunD to examine the effects on
LNCaP cells. Results showed that JunD overexpression
led to an increase in ROS production in a low-androgen
environment and that JunD was a necessary mediator of
androgen-induced oxidative stress (Mehraein-Ghomi
et al., 2008). Another study showed that androgens induce
the production of spermidine N1-acetyltransferase in a
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polyamine catabolic pathway, in which JunD directly
binds to a specific spermidine N1-acetyltransferase
sequence, and leads to an increase in ROS levels, thus
showing that androgen receptors need JunD as a
coactivator to activate an oxidative stress generation
pathway in LNCaP cells (Mehraein-Ghomi et al., 2010).
This illustrates how ROS, although obligate byproducts
of cell metabolism, can be harmful when unregulated.

Oxidative stress and its effects on senescence
and prostate cancer
Although ROS play a role in the initiation of prostate
cancer either by directly affecting nuclear DNA or
affecting transcription factors, they also create mutations
in mitochondrial DNA (mtDNA), which in turn are
believed to promote aging. Aging, also known as
senescence, is characterized by a lessened ability to
respond to stress stimuli and a progressive decline in
body functions at both cellular and tissue level. Many
theories have been devised to explain biological senescence, one of them being Harman’s ‘free radical theory of
aging’, which suggests that cells subjected to oxidative
stress have damage to biomolecules that leads to aging
(Harman, 2006). With age, an accumulation of somatic
mutations in mtDNA causes deficiencies in oxidative
phosphorylation and the electron transport chain, which
in turn cause both increased production of ROS and their
leakage into the cytoplasm. The accumulation of mtDNA
somatic mutations seems to be an indicator of human agerelated disorders, including prostate cancer, for which the
highest incidence occurs between 50 and 75 years of age
(Jemal et al., 2010).

Nitrosative stress and its effect on prostate
cancer
Increasing evidence suggests that reactive nitrogen
species (RNS) also play a major role in aging and,
therefore, age-related diseases such as prostate cancer
(Drew, 2002). When the levels of RNS such as nitric
–
oxide (NO) and its byproducts such as nitrate (NO3 ),
–
–
nitrite (NO2 ), and peroxynitrite (ONOO ) are increased, the cell is subjected to what is known as
nitrosative stress. Studies have shown that levels of RNS
are increased in prostate cancer tissues, thus suggesting a
potential role in the development of prostate cancer. A
clinical trial performed in Turkey and Macedonia
concluded that the plasma of patients with prostate
cancer contained higher levels of nitrate, nitrite, and
cyclic guanosine monophosphate, an indicator of NO
metabolism, than that of controls and patients with BPH
(Arsova-Sarafinovska et al., 2009).
The family of enzymes responsible for NO biosynthesis is
known as NO synthases (NOS). These enzymes are
involved in the production of neuronal NOS (NOS1),
calcium-independent inducible NOS (NOS2 or iNOS),
and calcium-dependent endothelial NOS (NOS3). Stu-

dies have shown that NOS2 is increased in prostate
cancer cells (Uotila et al., 2001). In addition, NOS3 has
been suggested to protect prostate cancer cells from
apoptosis by reducing their sensitivity to tumor necrosis
factor-related apoptosis-inducing ligand, an anticancer
agent that induces apoptosis in most tumor cells without
affecting normal cells (Tong and Li, 2004).
Interestingly, iNOS has been related to both stimulatory
and suppressive effects on the growth of cancer cells. One
study examined its role as a potential therapeutic target
for both the early and late stages of prostate cancer
(Coulter et al., 2010). Results showed that iNOS-induced
cytotoxicity in both androgen-dependent and androgenindependent prostate cancer cell lines, and NO production, had a positive correlation with an increased
cytotoxicity. Tumor growth delay was also observed in
iNOS-expressing cells, thus suggesting a potential role in
prostate cancer therapy.

Cell cycle and prostate cancer progression
Other targets that are being examined for their therapeutic potential besides NO species are molecules
involved in cell cycle checkpoints, as an uncontrolled
cell growth due to defects in the cell cycle helps in
propagating the development of prostate cancer. One
such molecule, cdk2ap1, is an S-phase growth suppressor
known to induce apoptosis and to decrease cell proliferation in squamous cell carcinomas (Zolochevska and
Figueiredo, 2009). A study showed cdk2ap1 expression
correlated with a decrease in cell growth due to cell cycle
arrest, apoptosis, and a decrease in the aggressive
phenotype of prostate cancer (Ishikawa et al., 2008).
Molecules with the ability to induce cell cycle arrest have
become important in the development of therapeutic
drugs that target both the early and late stages of cancer.
Many chemokines and cytokines are suspected to play a
role in the terminal stage of prostate cancer known as
androgen-independent prostate cancer, where the tumor
no longer depends on hormones for growth and is
resistant to therapy. One such chemokine is interleukin-8 (IL-8). A recent study investigated the role of IL-8
in the malignant progression of androgen-independent
prostate cancer by transfecting cells with IL-8 small
interfering RNA and comparing them with controls. They
concluded that IL-8 reduction led to cell cycle arrest at
the G1/S boundary and a decrease in cell cycle-regulated
proteins cyclin D1 and cyclin B1 (Singh and Lokeshwar,
2009). A 43% increase in apoptosis was also observed in
IL-8-depleted cells due to an increase in the activation of
caspase 9, a protein involved in the apoptotic pathway,
and a decrease in antiapoptotic proteins such as BCL-2.
The biological changes these prostate cancer cells
experienced made them more susceptible to the
cytotoxic activity of chemotherapeutic drugs such as
docetaxel, staurosporine, and rapamycin.
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Two other chemopreventive agents that have therapeutic
potential for prostate cancer are selenite and genistein.
Although selenite induces apoptosis only, genistein
induces both apoptosis and G2/M cell cycle arrest. When
these two compounds are combined, their effects are
enhanced and p53, a cell cycle regulator and tumor
suppressor protein, is increased in LNCaP cells (Zhao
et al., 2009). These two agents may serve as potential
ingredients in anticancer drugs and help slow down the
aggressive growth of prostate cancer during its latter
stages.
Cell cycle regulators have promising potential as therapeutic targets, as they can slow down the aggressive
phenotype of cells by making cancer cells more
susceptible to cytotoxic agents and chemotherapeutic
treatment, and can also arrest the cell cycle and,
therefore, prevent the uncontrolled development of
cancer.

Oxidative stress and its effect on apoptosis
and prostate cancer progression
An alternative way to prevent the progression of cancer is
through cell death. The two major mechanisms for cell
death are apoptosis, an organized, regulated process in
which the cell programs its own death, and necrosis, a
disorganized process in which the cell swells, disintegrates, and exudes cell contents that lead to inflammation. Decreased apoptosis plays a major role in tumor
progression, as failure of apoptosis leads to continual cell
growth and proliferation.
Studies have shown that the concentration of ROS in the
cell helps to determine which mechanism of death the
cell will undergo. Exposure of cancer cells to ROS
depletes the cells of their antioxidant capacity, and when
ROS levels exceed a certain threshold, the apoptotic
pathway is triggered (Kong et al., 2000). Depletion of
antioxidant defenses leads to the activation of stressresponsive transcription factors responsible for the
activation of genes involved in apoptosis. A recent study
showed how the increase in ROS leads to the activation of
the Jun N-terminal kinases/stress-activated protein
kinase signaling pathway, which is involved in both the
activation of genes and the posttranslational modifications of proteins involved in apoptosis (Haddad, 2004).
Other studies have demonstrated that H2O2 activates
caspase, a protein involved in the apoptotic pathway, and
that this is dependent on the release of cytochrome c
from the mitochondria, thus suggesting the importance of
H2O2 in mitochondrial permeability (Burkitt et al., 2005).
Although certain concentrations of ROS trigger apoptosis,
higher levels of ROS have also been shown to cause
necrosis in lymphoid cells (Villena et al., 2008) and liver
cancer cells (Lu et al., 2010). The effect of ROS in
necrosis of prostate cancer cells has yet to be examined.
Two possible mechanisms have been proposed to explain

how cell death through apoptosis can be switched to
necrosis. The first mechanism involves the inactivation of
caspase proteins due to the oxidation of their active thiol
group or S-nitrosylation, which can lead to cell death by
necrosis (Melino et al., 1997). The second mechanism
that could lead to a switch from apoptosis to necrosis is
the depletion of cellular ATP levels due to the failure of
energy production in the mitochondria caused by high
levels of oxidants (Miyoshi et al., 2006).
Although many studies have shown free radical species as
mediators of apoptosis, it has become more apparent that
different levels of ROS can have different effects on
cellular mechanisms. One study explored the effects of
varying concentrations of H2O2 on the proliferation of
PC-3 prostate carcinoma cells, which lack functional p53,
a tumor suppressor protein (Bataller and Portugal, 2005).
Results showed that in the presence of 50 mmol/l of
H2O2, cell cycle arrest was observed in the G2 phase,
along with p53-independent apoptosis. When the H2O2
concentration was increased to 500 mmol/l, an increased
percentage of apoptosis was observed, suggesting that
DNA damage by ROS can have adverse effects on the cell
and is far more complex than was initially thought.

Hypoxia and its effect on prostate cancer
progression
Another condition that aids in prostate cancer progression
and metastasis is hypoxia, which is characterized by a low
oxygen environment. Tumor cell growth is dependent on
a constant supply of oxygen and nutrients; however, when
the tumor mass reaches a critical size, the vasculature
becomes inadequate to sustain additional growth. When
cells are exposed to hypoxic conditions, tumor cells
release angiogenic growth factors that aid in the
development of necessary vasculature to maintain the
progression of the tumor (Cheema et al., 2010). Hypoxic
conditions cause the ROS levels to increase within the
tumor, thus contributing to the malignant phenotype of
prostate cancer and its resistance to radiation therapy
(Anastasiadis et al., 2003).
Hypoxia-inducible factor-1a (HIF-1a) is used as a marker
of hypoxia, and several studies have explored the role of
hypoxia in tumor growth and progression. It has been
shown that HIF-1a is overexpressed in primary prostate
cancers (Zhong et al., 1999) and in LNCaP cells in vitro
(Ghafar et al., 2003). Other studies have suggested that
HIF-1a upregulation occurs in the early stages of
carcinogenesis (Zhong et al., 2004), and it is believed to
help induce angiogenesis through the release of signals
that bind to rapamycin (mammalian target of rapamycin)
and thus activate a series of pathways (Vaupel, 2004). In
contrast, results of another study showed that systemic
hypoxia aided in tumor growth in athymic mice that were
xenografted with LNCaP cells regardless of HIF-1a
expression levels, thus suggesting the existence of
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HIF-1a-independent hypoxia-inducing pathways (Terraneo et al., 2010). Hypoxic conditions contribute to the
aggressive phenotype in prostate cancer cell lines by
turning on cell survival pathways that make tumor cells
unresponsive to many therapeutic treatments.

cancer samples studied (Yu et al., 2007). It also showed
that GPx suppressed colony formation, and when cells
expressing GPx were xenografted into mouse models,
they showed a reduced tumor volume and inability to
metastasize. All these studies suggest that GPx is a tumor
suppressor gene with therapeutic potential.

Endogenous antioxidants and their effect on
oxidative stress and prostate cancer

In addition to measuring levels of GPx, one study
measured the levels of additional antioxidant enzymes
such as catalase and copper zinc superoxide dismutase
(Arsova-Sarafinovska et al., 2009). This clinical trial, which
was performed to explore the prooxidant/antioxidant
balance in patients with prostate cancer in Turkey and
Macedonia, showed a decrease in GPx and copper zinc
superoxide dismutase in patients with prostate cancer
when compared with controls and patients with BPH,
thus suggesting the importance of these antioxidant
enzymes in limiting the progression of prostate growth.
Another study confirmed these results by reporting that
GST activity was significantly decreased in patients with
prostate cancer (Surapaneni and Venkata, 2006), whereas
others have observed an increase in ROS production in
prostate cancer cells compared with normal prostate cells
(Kumar et al., 2008).

Although many commercial companies are investigating
therapeutics that may reduce concentrations of ROS in
the cell, the body has its own defense mechanisms to
prevent and combat oxidative stress. Antioxidants,
molecules that inhibit oxidation, are known to protect
the cell against oxidative stress conditions by preventing
oxidant-induced damage. The antioxidant defense system involves enzymes such as those of the glutathione
redox system and enhancer elements such as antioxidant
response elements (ARE) that are activated in response
to high levels of ROS.
Glutathione redox system

The body maintains the antioxidant/oxidant balance
using the glutathione redox system, which involves
enzymes such as glutathione-s-transferases (GST) and
glutathione peroxidase (GPx). GST are a group of
enzymes that detoxify activated metabolites of procarcinogens produced by phase I reactions, and also determine
the cell sensitivity to different toxic chemicals (Hayes and
Pulford, 2003). One study found that genetic polymorphisms that altered the detoxifying activity of GSTs affected
the levels of procarcinogenic metabolites (Nock et al.,
2009). It specifically found that certain types of GST,
GSTTI null, and GSTP1, increased the risk of prostate
cancer biochemical recurrence in African-Americans but
not in Caucasians. Although explanations for these results
remain undetermined, the data still suggest the potential of
GSTs as therapeutic targets for prostate cancer.
GPx is another enzyme that is being investigated for its
therapeutic potential, as it acts as an electron donor to
peroxyl radicals, thus reducing oxidative stress within the
cell and thereby potentially helping in the prevention of
the development of prostate cancer. It is located in the
cytoplasm of prostate epithelial cells, and its depletion
has been associated with prostate cancer metastasis
(Aydin et al., 2009). One study revealed that mice with
mutations that suppressed GPx activity in the prostate
gland developed prostate cancer (Ouyang et al., 2005). In
another study, it was observed that increasing the expression of GPx in prostate cancer cells suppressed tumor
growth both in vitro and in vivo by downregulating the
expression of c-met, a tyrosine receptor tumor-transforming
gene and proto-oncogene that encodes for a protein called
hepatocyte growth factor receptor (Bottaro et al., 1991).
Another study found similar results, where the expression
of GPx was inactivated in prostate cancers, and deletions
of the GPx gene were observed in 39% of the prostate

Antioxidant response elements (AREs)

Another defense mechanism that the body uses to
combat ROS is the activation of transcription factors
that bind to the AREs. These sequences are found in
promoter regions of antioxidant genes, and when
activated, lead to the transcription of these genes (Jain
et al., 2010). AREs are regulated by a transcription factor
called erythroid-derived 2-related factor 2 that plays a
role in regulating ROS levels by regulating antioxidants
such as NADPH, quinone oxidoreductase, and heme
oxygenase. A study using transgenic adenocarcinoma of
the prostate mice showed that the loss of erythroidderived 2-related factor 2 led to elevated ROS levels and
DNA damage associated with tumorigenesis in the prostate
(Frohlich et al., 2008). This suggests the potential of these
regulatory components as therapeutic targets, as they are
responsible for maintaining the antioxidant/oxidant balance
that plays a major role in regulating the development of
prostate cancer malignancy.

Dietary antioxidants and their effect on
oxidative stress and prostate cancer
One of the predispositions that leads to the development
of prostate cancer is diet, which is why many studies have
emphasized the importance of certain vitamins in
decreasing prostate cancer risk. Dietary antioxidants such
as vitamin D, carotenoids, and lycopene aid in the body’s
defense against oxidation events.
Role of vitamin D in prostate cancer risk

Vitamin D is involved in the synthesis of NO synthase
and in the increased levels of glutathione. In a case study
of 19 000 men with prostate cancer, those with levels of
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25(OH)D, a vitamin D metabolite, below 16 ng/ml had a
70% higher incidence rate of prostate cancer than those
with higher levels of this metabolite. In addition, the
incidence of prostate cancer for younger men was 3.5
times higher if their levels were below 16 ng/ml (Ahonen
et al., 2000). This shows that vitamin D administration
may have significant effects on the initiation of colon and
prostate cancer. A study that examined the levels of
vitamin D receptors (VDR) of 841 patients with prostate
cancer showed that men with tumors that had a VDR
upregulation had a lower risk of lethal prostate cancer
(Hendrickson et al., 2010). There was also a positive
correlation observed between VDR expression and
androgen/estrogen receptors, suggesting that VDR acts
in an androgen-dependent or estrogen-dependent manner, thus emphasizing the potential role of vitamin D in
preventing the progression of prostate cancer.
Role of carotenoids in prostate cancer risk

Another important class of antioxidant compounds in
dietary supplements are carotenoids, which are naturally
occurring pigments found in plants that are known to be
powerful antioxidants. In one case–control study, carotenoid plasma levels of 118 non-Hispanic Caucasian men
suffering from nonmetastatic prostate cancer were
compared with those of 52 healthy men in Southeast
Texas (Chang et al., 2005). The results showed that the
cancer risk for men with high levels of a-carotene, transb-carotene, b-cryptoxanthin, lutein, and zeaxanthin in
their plasma was less than half that of those with low
levels of these compounds. When cancer aggressiveness
was examined in these patients, no correlation was found
between carotenoid plasma levels and aggressiveness of
disease. This study suggests that high plasma levels of
carotenoids may help reduce prostate cancer risk, but not
its progression.
Role of lycopene in prostate cancer risk

Similarly, another study demonstrated that the combination of lycopene and vitamin E inhibited the progression
of prostate cancer and extended survival in the orthotropic model of prostate cancer in nude mice (Trion et al.,
2007). In a different study, transgenic adenocarcinoma of
the prostate mice were fed with 10% whole tomato versus
a tomato-free diet to observe its effects on prostate
cancer tumor incidence and overall survival rate (Pannellini et al., 2010). Results showed that the tomato-rich diet
increased the overall survival rate and delayed the
progression of prostatic intraepithelial neoplasia to
adenocarcinoma. Lycopene, therefore, is an antioxidant
that warrant further study. Overall results have shown
that the presence of antioxidants, whether found in the
body naturally or increased by dietary supplements, have
antitumor and chemopreventive properties, and may
therefore be useful in preventing or delaying the
initiation of prostate cancer.

Conclusion
Prostate cancer is significant in terms of both morbidity
and mortality. Increased research on its prevention and
treatment is sorely needed. Two major conditions that
contribute to the malignant phenotype of prostate cancer
are when oxygen is lacking or when reactive forms of
oxygen or nitrogen are prevalent. The lack of oxygen
creates a hypoxic microenvironment, which leads to the
initiation of angiogenesis, which leads to a more
aggressive phenotype, whereas the generation of ROS
contributes to that phenotype through the activation of
oncogenes.
The body has several defenses to fight ROS, including
antioxidants that are either produced by the body or
acquired through diet. Research has shown that an
antioxidant-rich diet aids in the delay of prostate cancer
progression and helps reduce prostate cancer risk. By
ingesting an antioxidant-rich diet, the probability of
prostate cancer is reduced.

A compound that has been suggested to reduce prostate
cancer risk and its progression is lycopene. Lycopene is a
compound mainly found in tomato products, and it exerts
its antioxidant effects through the scavenging of free
radicals and induction of apoptosis. Lycopene has been
found to be associated with a lower prostate cancer risk in
a number of studies. Studies conducted in 1995 and 2004
supported the claim that lycopene intake through tomato
products resulted in a decreased risk of prostate cancer
(Giovannucci et al., 1995; Wu et al., 2004), whereas
another study did not find this inverse correlation (Kirsh
et al., 2006).

Prostate cancer prevention, although important, is not the
complete answer to this problem. More research should be
focused on finding novel therapeutic targets for future
prostate cancer drugs and treatments. Prostate cancer
diagnosis and prognosis techniques also require further
study. Although much knowledge has been gained relative
to different aspects of prostate cancer progression, the
more we understand about the molecular mechanisms that
operate in prostate cancer cells, the easier it will be to find
novel methods to treat this disease.

In another case–control study, it was shown that a daily
intake of commercial spaghetti sauce containing 30 mg of
lycopene in 200 g of sauce, 3 weeks before a radical
prostatectomy, resulted in decreased oxidative damage in
prostate cells compared with controls, and an increased
apoptosis in prostate cancer cells (Kim et al., 2003).
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